Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Titel:
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Auteur:
Grebely, Jason Conway, Brian Cunningham, Evan B. Fraser, Chris Moriggia, Alberto Gane, Ed Stedman, Catherine Cooper, Curtis Castro, Erika Schmid, Patrick Petoumenos, Kathy Hajarizadeh, Behzad Marks, Phillipa Erratt, Amanda Dalgard, Olav Lacombe, Karine Feld, Jordan J. Bruneau, Julie Daulouede, Jean-Pierre Powis, Jeff Bruggmann, Philip Matthews, Gail V. Kronborg, Ian Shaw, David Dunlop, Adrian Hellard, Margaret Applegate, Tanya L. Crawford, Sione Dore, Gregory J